Are there certain drugs that pharmacies may not compound due to FDA concerns?

The assertion that there are certain drugs that pharmacies may not compound due to FDA concerns is indeed true. The FDA has set forth regulations that prohibit the compounding of certain medications that have been found to pose significant safety risks. This can include drugs that are deemed to have a high potential for harm if compounded, especially if they have been withdrawn from the market for safety or efficacy reasons.

Furthermore, medications that have approved alternatives available on the market are generally not suitable for compounding. The FDA maintains a list of drugs that are not recommended for compounding, which reflects its commitment to ensuring patient safety and the integrity of drug formulations. This regulation helps mitigate risks associated with compounding practices, such as contamination or the lack of efficacy, thereby protecting public health.